Aminoglutethimide-induced leucopenia in a mouse model: Effects of metabolic and structural determinates

Environmental Toxicology and Pharmacology

Volumn 15, Issue 1, 2003, Pages 27-32

  Coleman, Michael D ^a   Khalaf, Laila F ^b   Nicholls, Paul J ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Agranulocytosis; Animal; Haemotoxicity; Leucopenia; Model; Platelet

Indexed keywords

3 (4 AMINOPHENYL)PYRROLIDINE 2,5 DIONE; 4 NITROGLUTETHIMIDE; AMINOGLUTETHIMIDE; AROMATASE INHIBITOR; CIMETIDINE; GLUTETHIMIDE; HAPTEN; PHENOBARBITAL; PROADIFEN; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CONTROLLED STUDY; COVALENT BOND; LEUKOCYTE COUNT; LEUKOPENIA; MALE; METABOLISM; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE;

ANIMALIA;

EID: 0344395254     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2003.08.003     Document Type: Article

References (25)

1. Ahmadi M., Khalaf L.F., Smith H.J., Nicholls P.J. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite. J. Pharm. Pharmacol. 48:1996;228.
2. Ali H., Nicholls P.J. Haematological effects of aminoglutethimide in the mouse. J. Pharm. Pharmacol. 38:1986;92P.
3. Ali H., Khalaf P., Nicholls P.J., Poole A. Comparison of in vitro and in vivo haemotoxic effects of aminoglutethimide and glutethimide. Toxicol. In Vitro. 4:1990;381.
4. Archer R.K. Haematological Techniques of Use on Animals. second ed :1965;Blackwell, Oxford.
5. Buttner M., Plank G., Heinritzi K. Effect of immunosuppressive treatment on eperythrozoon suis infection and porcine peripheral-blood natural killer (NK) cell activity. J. Vet. Med. 42:1995;301.
6. Caldwell G., Bradbury A., Toft A.D. Aminoglutethimide-induced agranulocytosis in breast cancer. Br. Med. J. 291:1985;970.
7. Coleman M.D. Dapsone toxicity: some current perspectives. Gen. Pharmacol. 26:1995;1461.
8. Coleman M.D. Dapsone mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology. 162:2001;53.
9. Coleman M.D., Winn M.J., Breckenridge A.M., Park B.K. Inhibition of dapsone-induced methaemoglobinaemia in the rat. Biochem. Pharmacol. 39:1990;802.
10. Dale C.C., Cottle T.E., Fier C.J., et al. Severe chronic neutropenia: treatment and follow up of patients in the severe chronic neutropenia international registry. Am. J. Hematol. 72:2003;82.
11. Daly M.J., Jones G.W., Nicholls P.J., Smith H.J., Rowlands M.G., Bunnett M.A. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione. J. Med. Chem. 29:1986;520.
12. Guest I., Sokulok B., MacCrimmon J., Uetrecht J.P. Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. Toxicology. 131:1998;53.
13. Harris A.L., Hughes G., Barrett A.J., Abusrewil S., Dowsett M., Smith I.E. Br. J. Cancer. 54:1986;119.
14. Johnson P.E., Buzdar A. Are differences in the available aromatase inhibitors and inactivators significant? Clin. Cancer Res. 7:2001;4360S.
15. Moeschlin S., Wagner K. Agranulocytosis due to the occurrence of leukocyte-agglutinins. Acta Haematol. 8:1952;29-41.
16. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. 221:1964;253.
17. Park B.K., Coleman J.W., Kitteringham N.R. Drug disposition and drug hypersensitivity. Biochem. Pharm. 36:1988;581.
18. Peterson M.E., Aucion D.P., Hurvitz A.I., Quimby F.W., Piccolie A., Drayer D.E., Reidenberg M.M. Propylthiouracil-induced immune-mediated disease in the cat. Clin. Pharm. Ther. 35:1984;266.
19. Riley R.J., Maggs J.L., Lambert C., Kitteringham N.R., Park B.K. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br. J. Clin. Pharm. 26:1988;577.
20. Uetrecht J.P. The Role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab. Rev. 24:1992;299.
21. Uetrecht J.P. Reactive metabolites and agranulocytosis. Eur. J. Haematol. 57:1996;83.
22. Uetrecht J.P. N-oxidation of drugs associated with idiosyncratic reactions. Drug Met. Rev. 34:2002;681.
23. Uetrecht J.P., Zahid N., Shear N.H., Rubin R. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. J. Pharmacol. Exper. Ther. 245:1988;274.
24. Uetrecht J.P., Shear N.H., Zahid N. N-chlorination of sulfamethazole and dapsone by the myeloperoxidase system. Drug Metab. Disp. 21:1993;830.
25. Vincent M.D., Clink H.M., Coombes R.C., Smith I.E., Kandler R., Powles T.J. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer. Br. Med. J. 291:1985;105.